J&J Expects EPO Pricing Injunction Ruling In Early 2006
If the court fails to grant a preliminary injunction against Amgen, "tremendous price pressure" will be reinjected into the EPO market, the Procrit marketer tells analysts.
If the court fails to grant a preliminary injunction against Amgen, "tremendous price pressure" will be reinjected into the EPO market, the Procrit marketer tells analysts.